Recombinant Human B4GALT1

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Recombinant Human B4GALT1
category
Proteins and Peptides
provider
FineTest
reference
Pr22511
tested applications
Western Blot, ELISA
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Host | Mammalian Cells |
Reactivity | Human |
Observed MW | 50-60 kDa |
Expression | Gly44-Ser398 (Tyr285Leu) |
Purity | Greater than 95% as determined by SDS-PAGE. |
Size 1 | 10μg |
Size 2 | 50μg |
Size 3 | 500μg |
Size 4 | 1mg |
Form | Liquid |
Tested Applications | Western Blot, ELISA |
Buffer | 0.2 μm filtered solution of 20 mM Tris, 150 mM NaCl, 2 mM EDTA, 20% Glycerol, pH 8.0. |
Availability | 7 days |
Storage | The protein solution is stable at -80°C for 6 months after receipt, and for 3 months under sterile conditions after opening. Avoid repeated freeze/thaw cycle. |
UniProt ID | P15291 |
Alias | 1,4- galactosyltransferase, polypeptide 1, B4GalT1, B4GAL-T1, beta-1,4-galactosyltransferase 1, Beta-1,4-GalTase 1, beta4Gal-T1, betaGlcNAc beta, CDG2D, GT1, GTB |
Background | Protein B4GALT1 |
Status | RUO |
Note | Endotoxin: < 1 EU/µg as determined by LAL test. Tag : C-terminal His Tag |
Related Products

Recombinant Human B4GALT1
Ver Producto
Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody
Rabbit polyclonal antibody against B4GALT1 protein. Immunogen region is C-terminal.
Ver Producto
Beta-1,4-Galactosyltransferase 1 (B4GALT1) Antibody
B4GalT1 is an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing.
Ver Producto